FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Inactive Instrument

Highlights Frazier Lifesciences Acquisition Corporation

Equities

FLAC

KYG3710A1058

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NewAmsterdam Pharma B.V. completed the acquisition of Frazier Lifesciences Acquisition Corporation from a group of shareholders in a reverse merger transaction.	22-11-21	CI
Frazier Lifesciences Shareholders Approve Merger With NewAmsterdam Pharma Holding	22-11-15	MT
Frazier Lifesciences Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Frazier Lifesciences Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Frazier Lifesciences Acquisition : NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger - Form 8-K/A	22-07-25	PU
NewAmsterdam Pharma to Go Public in Deal With Frazier Lifesciences SPAC	22-07-25	MT
Frazier Lifesciences Acquisition : NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger - Form 8-K	22-07-25	PU
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic Diseases	22-07-25	BU
NewAmsterdam Pharma B.V. entered into a definitive business combination agreement to acquire Frazier Lifesciences Acquisition Corporation from a group of shareholders for approximately $490 million.	22-07-24	CI
Frazier Lifesciences Acquisition Negotiates Business Combination With NewAmsterdam Pharma	22-07-20	MT
Frazier Lifesciences Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Frazier Lifesciences Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
FRAZIER LIFESCIENCES ACQUISITION CORP - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.	22-01-31	AQ
FRAZIER LIFESCIENCES ACQUISITION CORP : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	22-01-26	AQ
Frazier Lifesciences Acquisition Corporation has completed an IPO in the amount of $120 million.	20-12-08	CI
Frazier Lifesciences Acquisition Corporation has filed an IPO in the amount of $100 million.	20-11-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
FLAC Stock
News Frazier Lifesciences Acquisition Corporation
Highlights

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW